| 1 |
Sung H, Ferlay J, Siegel R L，et al.Global Cancer Statistics 2020：GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries[J]．CA Cancer J Clin，2021，71(3):209-249.
|
| 2 |
Mizushima N, Komatsu M．Autophagy：renovation of cells and tissues[J]．Cell，2011，147(4):728-741.
|
| 3 |
杨晨，李萍，梁廷明．细胞自噬与肿瘤的关系研究进展[J]．生命科学，2015，27(2):151-160.
|
| 4 |
Arzumanyan A, Reis HM, Feitelson MA.Pathogenic mechanisms in HBV-and HCV-associated hepatocellular carcinoma[J]．Nat Rev Cancer，2013，13(2):123-135.
|
| 5 |
Yazdani H, Huang H, Tsung A．Autophagy：Dual Response in the Development of Hepatocellular Carcinoma[J]．Cells，2019，8(2):91.
|
| 6 |
Ba L, Gao J, Chen Y，et al.Allicin attenuates pathological cardiac hypertrophy by inhibiting autophagy via activation of PI3K/Akt/mTOR and MAPK/ERK/mTOR signaling pathways[J]．Phytomedicine，2019，58:152765.
|
| 7 |
Feng Z, Zhang H, Levine A J，et al.The coordinate regulation of the p53 and mTOR pathways in cells[J]．Proc Natl Acad Sci U S A，2005，102(23):8204-8209.
|
| 8 |
Ma S, Meng Z, Chen R，et al.The Hippo Pathway：Biology and Pathophysiology[J]．Annu Rev Biochem，2019，88:577-604.
|
| 9 |
徐潇，任静，张嘉炜，等．MOB2敲低表达调控NDR1/2-YAP对肝癌细胞迁移和细胞自噬的研究[J]．扬州大学学报(农业与生命科学版)，2020，41(3):30-36.
|
| 10 |
Cervello M, Bachvarov D, Lampiasi N，et al.Molecular mechanisms of sorafenib action in liver cancer cells[J]．Cell Cycle，2012，11(15):2843-2855.
|
| 11 |
Mendez-Blanco C, Fondevila F, Garcia-Palomo A，et al.Sorafenib resistance in hepatocarcinoma：role of hypoxia-inducible factors[J]．Exp Mol Med，2018，50(10):1-9.
|
| 12 |
Rodriguez-Hernandez MA, Gonzalez R, De La Rosa AJ，et al.Molecular characterization of autophagic and apoptotic signaling induced by sorafenib in liver cancer cells[J]．J Cell Physiol，2018，234(1):692-708.
|
| 13 |
Rodriguez-Hernandez MA, De La Cruz-Ojeda P, Gallego P，et al.Dose-dependent regulation of mitochondrial function and cell death pathway by sorafenib in liver cancer cells[J]．Biochem Pharmacol，2020，176:113902.
|
| 14 |
Lin Z, Niu Y, Wan A，et al.RNA m(6)A methylation regulates sorafenib resistance in liver cancer through FOXO3-mediated autophagy[J]．EMBO J，2020，39(12):e103181.
|
| 15 |
马丽锋，郝六平，李丽娟，等．麝香酮的药理与合成研究进展[J]．河北化工，2010，33(2):11-14.
|
| 16 |
Qi W, Li Z, Yang C，et al.Inhibitory mechanism of muscone in liver cancer involves the induction of apoptosis and autophagy[J]．Oncol Rep，2020，43(3):839-850.
|
| 17 |
Ruan C, You L, Qiu Y，et al.Tubeimoside I induces autophagy in HepG2 cells by activating the AMP-activated protein kinase signaling pathway[J]．Oncol Lett，2020，20(1):623-630.
|
| 18 |
Jia G, Wang Q, Wang R，et al.Tubeimoside-1 induces glioma apoptosis through regulation of Bax/Bcl-2 and the ROS/Cytochrome C/Caspase-3 pathway[J]．Onco Targets Ther，2015，8:303-311.
|
| 19 |
Zhang Y, Xu X M, Zhang M，et al.Effects of tubeimoside-1 on the proliferation and apoptosis of BGC823 gastric cancer cells in vitro[J]．Oncol Lett，2013，5(3):801-804.
|
| 20 |
Hosseinzadeh H, Nassiri-Asl M．Pharmacological Effects of Glycyrrhiza spp.and Its Bioactive Constituents：Update and Review[J]．Phytother Res，2015，29(12):1868-1886.
|
| 21 |
Abo El-Magd N F, El-Mesery M, El-Karef A，et al.Glycyrrhizin ameliorates high fat diet-induced obesity in rats by activating NrF2 pathway[J]．Life Sci，2018，193:159-170.
|
| 22 |
Zhang E, Yin S, Zhao S，et al.Protective effects of glycycoumarin on liver diseases[J]．Phytother Res，2020，34(6):1191-1197.
|
| 23 |
Zhang Y L, Guo H, Zhang C S，et al.AMP as a low-energy charge signal autonomously initiates assembly of AXIN-AMPK-LKB1 complex for AMPK activation[J]．Cell Metab，2013，18(4):546-555.
|
| 24 |
Song X, Yin S, Zhang E，et al.Glycycoumarin exerts anti-liver cancer activity by directly targeting T-LAK cell-originated protein kinase[J]．Oncotarget，2016，7(40):65732-65743.
|
| 25 |
Reina-Campos M, Diaz-Meco MT, Moscat J．The Dual Roles of the Atypical Protein Kinase Cs in Cancer[J]．Cancer Cell，2019，36(3):218-235.
|
| 26 |
Kudo Y, Sugimoto M, Arias E，et al.PKClambda/iota Loss Induces Autophagy，Oxidative Phosphorylation，and NRF2 to Promote Liver Cancer Progression[J]．Cancer Cell，2020，38(2):247-262 e211.
|
| 27 |
Zhao Y, Wu H, Xing X，et al.CD13 Induces Autophagy to Promote Hepatocellular Carcinoma Cell Chemoresistance Through the P38/Hsp27/CREB/ATG7 Pathway[J]．J Pharmacol Exp Ther，2020，374(3):512-520.
|
| 28 |
Wickstrom M, Larsson R, Nygren P，et al.Aminopeptidase N(CD13)as a target for cancer chemotherapy[J]．Cancer Sci，2011，102(3):501-508.
|
| 29 |
Tsuboyama K, Koyama-Honda I, Sakamaki Y，et al.The ATG conjugation systems are important for degradation of the inner autophagosomal membrane[J]．Science，2016，354(6315):1036-1041.
|
| 30 |
Zhang H．CCND1 silencing suppresses liver cancer stem cell differentiation through inhibiting autophagy[J]．Hum Cell，2020，33(1):140-147.
|
| 31 |
Chen J, Li X, Cheng Q，et al.Effects of cyclin D1 gene silencing on cell proliferation，cell cycle，and apoptosis of hepatocellular carcinoma cells[J]．J Cell Biochem，2018，119(2):2368-2380.
|
| 32 |
Wang C, Jiang X, Li X，et al.Long noncoding RNA HULC accelerates the growth of human liver cancer stem cells by upregulating CyclinD1 through miR675-PKM2 pathway via autophagy[J]．Stem Cell Res Ther，2020，11(1):8.
|
| 33 |
Aggarwal BB, Gupta SC, Kim JH.Historical perspectives on tumor necrosis factor and its superfamily：25 years later，a golden journey[J]．Blood，2012，119(3):651-665.
|
| 34 |
Niture S, Dong X, Arthur E，et al.Oncogenic Role of Tumor Necrosis Factor alpha-Induced Protein 8(TNFAIP8)[J]．Cells，2018，8(1):9.
|
| 35 |
Niture S, Gyamfi M A, Lin M，et al.TNFAIP8 regulates autophagy，cell steatosis，and promotes hepatocellular carcinoma cell proliferation[J]．Cell Death Dis，2020，11(3):178.
|